EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark QURE-HDL was filed as Word mark on 06/16/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/29/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018494449 |
| Application date | June 16, 2021 |
| Publication date | June 22, 2021 |
| Entry date | September 29, 2021 |
| Expiration date | June 16, 2031 |
Trademark owner
Paasheuvelweg 25
1105 BP Amsterdam
NL
1105 BP Amsterdam
NL
Trademark representatives
Rembrandt Tower, 28th Floor, Amstelplein 1
1096 HA Amsterdam
NL
goods and services
5
Viral systems, gene therapy systems, nucleic acid delivery systems, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other products for use in nucleic acid-based therapy, gene therapy and cell therapy
42
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; Research and product development in the field of pharmaceutics
44
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; Consultancy in the field of pharmaceutics
ID: 11018494449